Safety Policies & Visitor Guidelines |
Appointments & Scheduling |
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Abramson Cancer Center, Farm Journal Building, 2nd Floor
230 West Washington Square
Philadelphia, PA 19106
The Patient Satisfaction Rating is an average of all responses to the care provider related question shown below from a 3rd party vendor, Press Ganey and as of 7/01/21, our internal platform, PMX Feedback. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
John G. Gribben, MD DSc, FRCP, FRCPath, FMedSci, Wojciech Jurczak, MD PhD, Ryan W. Jacobs, MD, Sebastian Grosicki, MD PhD, Krzysztof Giannopoulos, MD PhD, Tomasz Wrobel, MDPhD, Syed F. Zafar, MD, Jennifer L. Cultrera, MD, Suman Kambhampati, MD, Alexey Danilov, MD, John M. Burke, MD, Jerome Goldschmidt, MD, Douglas F. Beach, MD, Scott F. Huntington, MD MPH, Javier Pinilla Ibarz, MD PhD, Jeff P Sharman, MD, Tanya Siddiqi, MD, Danielle M. Brander, MD, John M. Pagel, MDPhD, Kathryn S. Kolibaba, MD, Monika Dlugosz-Danecka, MD PhD, Nilanjan Ghosh, MD PhD, Peter Sportelli, BS, Hari P. Miskin, MSc, Owen A. O'Connor, MD PhD, Michael S. Weiss, Ian W. Flinn, MD PhD: Umbralisib Plus Ublituximab (U2) Is Superior to Obinutuzumab Plus Chlorambucil (O+Chl) in Patients with Treatment Naïve (TN) and Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from the Phase 3 Unity-CLL Study Blood (2020) 136 (Supplement 1): 37–39. 136 : 37–39,2020.
Riley SV, Beach DF.: Making Progress: Impact of Diabetes on Metastatic Colon Cancer Disease Progression.
J. Neoplasm. 5 (1:1): 2020.
Mato, A. R., Roeker, L. E., Allan, J. N., Pagel, J. M., Brander, D. M., Hill, B. T., Cheson, B. D., Furman, R. R., Lamanna, N., Tam, C. S., Handunnetti, S., Jacobs, R., Lansigan, F., Bhavsar, E., Barr, P. M., Shadman, M., Skarbnik, A. P., Goy, A., Beach, D. F., Svoboda, J., Pu, J. J., Sehgal, A. R., Zent, C. S., Tuncer, H. H., Schuster, S. J., Pickens, P. V., Shah, N. N., Rhodes, J., Ujjani, C. S., Nabhan, C.: Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.
Am J Hematol 93 (11): 1394-1401,2018.
Oren O, Oren M, Beach D: On the generalizability of prostate cancer studies: why race matters.
Ann Oncol 27 (12): 2146-2148,2016.
Grant S, Meykler S, Beach D: Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma. J Community Support Oncol 12 (11): 415-417,2014.
Beach DF, Barnoski B, Patel V, Schwarting R, Strair R, Lachant N: Duplication of chromosome 1 [dup(1)(q21q32)] as the sole cytogenetic abnormality in a patient previously treated for AML. Cancer Genetics 205 (12): 665-668,2012.
Beach DF, Klump W, Haddad G, Reid LM, Schwarting R, Hageboutros A.: Extrapulmonary small cell: a novel case of small cell carcinoma of the thyroid gland. Medical Oncology 29 (3): 1405-1408,2012.
Beach D, Somer R: Metastatic Renal Cell Carcinoma to the Phalanx. Urology 79 (5): e77,2012.
Beach-Rak Medicine LLC: Master Diagnostician Series: Acute Kidney Injury iPhone application for diagnosing and managing AKI. : 2012.
Beach DF, Somer R: A Wealth of New Options: A Case Presentation of the Management of Castration-Recurrent Prostate Cancer Seminars in Oncology 39 (1): 1-8,2012.
Penn Hematology/Oncology230 W. Washington Square, 2nd Floor
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.